Afuco™ Anti-Human TLR3 ADCC Therapeutic Antibody (IPH33), ADCC Enhanced
Anti-TLR3 ADCC Enhanced Antibody (IPH33) is an ADCC enhanced antibody produced by our Afuco™ platform. IPH33 is a monoclonal antibody targeting the Toll-like Receptor-3 receptor (TLR3), it can be used in a broad spectrum of chronic inflammatory indications, such as COPD, IBD, RA.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-590CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | TLR3 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | FuncS |
| Storage | Can be stored at 4°C. For long term storage, aliquot and store at -20°C. Avoid repeated freezing and thawing cycles. |